Education
About Us
Working with TipRanks
Follow Us
Definitive Healthcare Corp (DH)
NASDAQ:DH
DH Stock Chart & Stats
$1.13
-$0.06(-1.41%)
At close: 4:00 PM EST
$1.13
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$0.97 - $4.70
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$161.38M
Enterprise Value$132.24M
Total Cash (Recent Filing)$180.89M
Total Debt (Recent Filing)$177.82M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Apr 30, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding104,472,374
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap0.82
Enterprise Value/Revenue0.55
Enterprise Value/Gross Profit0.72
Enterprise Value/Ebitda-0.90
Forecast
1Y Price Target
$2.98Price Target Upside163.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)0.18
Revenue Forecast (FY)$223.61M
Bulls Say, Bears Say
Bulls Say
Customer RetentionImproved gross revenue retention and rising gross dollar retention point to more stable recurring revenue and lower downside from customer attrition.
Enterprise Go-to-market FocusA strategic shift toward deeper integration with enterprise customers can expand net dollar retention and make revenue more predictable if execution progresses.
Product Innovation And IntegrationsPlatform enhancements, the addition of a new claims data source, and expanded integrations with major data platforms strengthen the product offering and support future upsell opportunities.
Bears Say
Cost Structure And Profitability PressureA fixed cost structure means slower top line growth quickly erodes profitability, heightening downside risk until revenue momentum improves or costs are adjusted.
Revenue Trajectory And GuidanceShrinking revenue combined with management signaling further declines increases uncertainty about the timing of a sustained recovery and pressures investor sentiment.
Weak Upsell And Retention MetricsPersistently weak upsell and cross sell performance, with net dollar retention below desired levels, constrains organic growth potential and relies more on new sales to drive revenue.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.97 and its highest was $4.70 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $161.38M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Apr 30, 2026 which is in 37 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on Feb 26, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.061 by -$0.001.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.03.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 104,472,374 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.06 in its last earnings report, missing expectations of $0.061. Following the earnings report the stock price went down -8.571%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.98 (163.72% Upside)
$2.98 (163.72% Upside)
Hedge Fund Trend
Increased
By 63.9K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
-47.69%
Trailing 12-Months
Asset Growth
-45.86%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed but stabilizing picture: strong profitability, cash generation and operational progress (claims data remediation, faster integrations, digital activation traction and AI roadmap) are meaningful positives, while top-line weakness, reduced multi-year contract durations, and soft net dollar retention/upsell pressure continue to weigh on near-term growth. Management guided conservatively for 2026 with continued investment in product and integrations and expects NDR and revenue to improve later in the year as those investments and data fixes take hold.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$2.98
▲(163.72% Upside)
Technical Analysis
Ownership Overview
12.64% Insiders
4.37% Mutual Funds
61.58% Other Institutional Investors
15.63% Public Companies and
Individual Investors